Qingdao Baheal Medical INC. (301015) — Capital Reinvestment Ratio
Qingdao Baheal Medical INC. (301015) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥230.38 Million) in capital expenditures (CN¥107.50 Million). Check Qingdao Baheal Medical INC. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Baheal Medical INC. Capital Reinvestment Ratio (2018–2025)
This chart tracks Qingdao Baheal Medical INC.'s Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Qingdao Baheal Medical INC. (301015) cash flow conversion.
Annual Capital Reinvestment Ratio for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Baheal Medical INC. from 2018 to 2025. See Qingdao Baheal Medical INC. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥934.45 Million | CN¥288.93 Million | ▼ -17.2% |
| 2024 | 0.37x | CN¥813.85 Million | CN¥303.99 Million | ▲ +61.0% |
| 2023 | 0.23x | CN¥799.50 Million | CN¥185.49 Million | ▼ -32.6% |
| 2022 | 0.34x | CN¥305.75 Million | CN¥105.32 Million | ▲ +127.2% |
| 2021 | 0.15x | CN¥181.30 Million | CN¥27.49 Million | ▲ +135.9% |
| 2019 | 0.06x | CN¥45.96 Million | CN¥2.95 Million | ▼ -77.3% |
| 2018 | 0.28x | CN¥55.50 Million | CN¥15.74 Million | — |